Giuliana Grossi

Sickle cell warriors are empowered to be part of the research and to be part of the solution, Regina Hartfield says.

Isatuximab in combination with carfilzomib and dexamethasone (Kd) demonstrate the longest median progression free survival (mPFS) on a proteasome inhibitor backbone in multiple myeloma patients who relapsed after a prior therapy, including lenalidomide.

Investigators who say that assessing vaso-occlusive crises solely through medical utilization doesn’t provide a full picture of the SCD experience because many VOCs are managed from home, are now backed by research.

Dr. Carolyn Rowley is leading the California Sickle Cell Disease Mental Health and Wellness Initiative to provide mental health services free to people living with sickle cell disease.

President and CEO of SCDAA Regina Hartfield discusses how the association will use the funds from the leadership award.

Dr. Gerald Smetana encourages PCPs to familiarize themselves with the outpatient drug options for managing COVID-19 because of the limited treatment window for administration.

Expert psychiatrist Dr. Timothy Fong explains the complexity of using marijuana as treatment in a primary care setting and shares advice on how to address it with patients.

Maternal-fetal medicine specialist Dr. Michael Aziz shines a light on the leading complications for pregnant patients and why the US has the highest maternal mortality rate.

At Pri-Med West, primary care providers ask Dr. Michael Ziffra and Dr. Shirah Vollmer all the questions they have about treating mental illness and prescribing different classes of drugs.

Dr. Shirah Vollmer and Dr. Michael Ziffra host a Question & Answer Session addressing common inquiries about mental health treatment in the primary care setting.

Expert nephrologist Dr. Rajeev Raghavan elaborates on the American Diabetes Association guideline updates for patients with diabetic kidney disease during Pri-Med West.

Dr. Rajeev Raghavan talks about the role of SGLT2 inhibitors and GLP-1 receptor agonists as new therapeutics available to slow progression of chronic kidney disease.

Pri-Med West presenter Dr. Rajeev Raghavan highlights the key points of his nephrology talk and identifies trending topics in the field during an interview.

Pri-Med West presenter, Dr. Peng Thim Fan asks the questions that many rheumatologists have likely been contemplating now that disease treatment is so successful.

While some physicians might initially assume that oral medications like upadacitinib aren't as effective as an injection, but Dr. Fan explains that's not the case.

Expert rheumatologist Dr. Peng Thim Fan explains that the effects of COVID-19 are still being examined.

Amid major national judicial and legislative deliberation on reproductive health care access, the Brigham and Women's and Harvard University expert joins to discuss the clinical matters of abortion.

Expert gynecologist Dr. Deborah Bartz addresses the clinical implications of an abortion ban if Roe v. Wade is overturned.

The azole antifungal treatment was approved by the FDA to reduce the incidence of recurrent vulvovaginal candidiasis, or chronic yeast infection.

The completion of this study concluded the planned clinical development program for nasal nalmefene and the company expects to file a New Drug Application in the second half of 2022.

This episode features a conversation with Dr. Amelle Shillington and Jacob and Ashley Wiley after Shillington diagnosed the extremely rare genetic disease that's afflicted Aislynn Wiley, and only 69 other documented cases worldwide.

ANCA-associated vasculitis may present like sinusitis, but it typically affects multiple organ systems.

Voxelotor is the first and only FDA-approved medication for children with sickle cell disease.

Emergency medicine specialist urges hospitals to add methylnaltrexone to the hospital formulary after promising research shows the treatment's success with opioid-induced constipation.

Dr. Warrington discusses the details of glucocorticoids and how avacopan can help with the effective treatment of ANCA-associated vasculitis.

Investigators assess the connection between PAPP-A MoM and fibroid size in pregnant women.

methylnaltrexone is more effective, less costly, and can even keep some patients out of the hospital after being treated for opioid-induced constipation in the emergency department.

Infants born to mothers with autoimmune disease had a 16% higher risk of being diagnosed with a mental disorder compared with those who were not prenatally exposed to maternal autoimmune diseases.

A new method of opioid disposal was proposed by the FDA in an attempt to mitigate unauthorized access to opioids and lessen risk of addiction.

Acadia Pharmaceuticals evaluated the effects of its novel redox modulator drug on pain intensity levels of patients undergoing a bunionectomy.